Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Implantable cardioverter defibrillator use in...
Journal article

Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe

Abstract

BACKGROUND AND AIMS: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmogenic right ventricular cardiomyopathy (ARVC). This study aims to identify cross-continental differences in utilization of primary prevention ICDs and survival free from sustained ventricular arrhythmia (VA) in ARVC. METHODS: This was a retrospective analysis of ARVC patients without prior VA enrolled in …

Authors

Carrick RT; De Marco C; Gasperetti A; Bosman LP; Gourraud J-B; Trancuccio A; Mazzanti A; Murray B; Pendleton C; Tichnell C

Journal

European Heart Journal, Vol. 45, No. 7, pp. 538–548

Publisher

Oxford University Press (OUP)

Publication Date

February 16, 2024

DOI

10.1093/eurheartj/ehad799

ISSN

0195-668X